Is there any association between nesfatin-1 and generalized anxiety disorder?

CELİK HELVACI, Fatmagul; HOCAOĞLU, Çiçek; BAHCECİ, Ilkay; GONUL, Yucel; BAĞCIOĞLU, Erman; Dilek, Aziz Ramazan; BAHÇECİ, Bülent

Is there any association between nesfatin-1 and generalized anxiety disorder?

Bülent BAHÇECİ, (Recep Tayyip Erdoğan Üniversitesi, Tıp Fakültesi Psikiyatri Anabilim Dalı, Rize, Türkiye)

Erman BAĞCIOĞLU, (Afyon Kocatepe Üniversitesi, Tıp Fakültesi, Psikiyatri Anabilim Dalı, Afyon, Türkiye)

Aziz Ramazan DİLEK, (Recep Tayyip Erdoğan Üniversitesi, Tıp Fakültesi, Mikrobiyoloji Anabilim Dalı, Rize, Türkiye)

Fatmagul CELİK HELVACI, (Afyon Kocatepe Üniversitesi, Tıp Fakültesi, Psikiyatri Anabilim Dalı, Afyon, Türkiye)

Ilkay BAHCECİ, (Recep Tayyip Erdoğan Üniversitesi, Tıp Fakültesi, Mikrobiyoloji Anabilim Dalı, Rize, Türkiye)

Yucel GONUL, (Afyon Kocatepe Üniversitesi, Tıp Fakültesi, Anatomi Anabilim Dalı, Afyonkarahisar, Türkiye)

Çiçek HOCAOĞLU (Afyon Kocatepe Üniversitesi, Tıp Fakültesi, Psikiyatri Anabilim Dalı, Afyon, Türkiye)

Klinik Psikofarmakoloji Bülteni

2 2

Yıl: 2014 Cilt: 24 Sayı: 1 Sayfa Aralığı: 55 - 58 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Is there any association between nesfatin-1 and generalized anxiety disorder?

Öz:

Amaç: Bu çalışmanın amacı yaygın anksiyete bozukluğu(YAB)’nun patogenezinde nesfatin-1’in olası rolünü araştırmaktır. Yöntem: Bu çalışmada 40 YAB’lu hasta ile yaş ve BMIile eşleştirilmiş 42 sağlıklı kontrol’un plasma nesfatin-1düzeyleri ölçüldü. Anksiyete şiddeti Hamilton Anksiyete Derecelendirme Ölçeği (HAM-A) ile değerlendirildi. Bulgular: Hasta ve kontrol grupları arasında nesfatin-1düzeyinde anlamlı bir farklılık yoktur. Ortalama serumnesfatin-1 düzeyi yaş, hastalık süresi, BMI ve HAM-Askoru ile korelasyon göstermiyordu. Sonuç: Sonuçlarımız YAB‘nun nesfatin-1 ile ilişkiliolduğunu desteklemiyor.

Anahtar Kelime:

Konular: Farmakoloji ve Eczacılık

Nesfatin-1 ve yaygın anksiyete bozukluğu arasında ilişki var mı?

Öz:

Objective: The aim of the present study was to find out the possible role of nesfatin-1 in the pathogenesis of generalized anxiety disorder (GAD). Methods: In this study, we measured plasma nesfatin-1 levels in 40 GAD patients and 42 controls that were matched by age and BMI. The severity of anxiety was evaluated with the Hamilton Anxiety Rating Scale (HAM-A). Results: There was no statistically significant difference in the nesfatin-1 levels between patient and control groups. The mean serum nesfatin-1 level did not show any correlation with age, duration of illness, BMI, HAM-A scores in the patient and control groups. Conclusion: Our results do not support that nesfatin-1 is associated with GAD.

Anahtar Kelime:

Konular: Farmakoloji ve Eczacılık

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, (4th ed, text revision). Washington, D:American Psychiatric Association, 2000.
2. Connor KM, Davidson JR. Generalized anxiety disorder: neurobiological and pharmacotherapeutic perspectives. Biol Psychiatry 1998;44(12):1286-94. [CrossRef]
3. Korpi ER, Grunder G, Luddens H. Drug interactions at GABA (A) receptors. Prog Neurobiol 2002;67(2):113-59. [CrossRef]
4. Strawn JR, Wehry AM, Delbello MP, Rynn MA, Strakowski S. Establishing the neurobiologic basis of treatment in children and adolescents with generalized anxiety disorder. Depress Anxiety 2012;29(4):328-39. [CrossRef]
5. Lohoff FW, Aquino TD, Narasimhan S, Multani PK, Etemad B, Rickels K. Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder. Pharmacogenomics J 2013;13(1):21-6. [CrossRef]
6. Iny LJ, Pecknold J, Suranyi-Cadotte BE, Bernier B, Luthe L, Nair NP, et al. Studies of a neurochemical link between depression, anxiety, and stress from (3H) imipramine and (3 H) paroxetine binding on human plateletes. Biol Psychiatry 1994;36(5):281-91. [CrossRef]
7. Garvey MJ, Noyes R Jr, Woodman C, Laukes C. The association of urinary 5-hydroxyindoleacetic acid and vanillylmandelic acid in patients with generalized anxiety. Neuropsychobiolgy 1995;31(1):6-9. [CrossRef]
8. Brawman-Mintzer O, Lydiard RB, Bradwejn J, Villarreal G, Knapp R, Emmanuel N, et al. Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder. Am j Psychiatry 1997;154(5):700-2.
9. Oh-I S, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006;443(7112):709-12. [CrossRef]
10. Palasz A, Krzystanek M, Worthington J, Czajkowska B, Kostro K, Wiaderkiewicz et al. Nesfatin-1, a unique regulatory neuropeptide of the brain. Neuropeptides 2012;46(3):105- 12. [CrossRef]
11. Price TO,Samson WK, Niehoff ML, Banks WA. Permeability of the blood-brain barrier to a novel satiety molecule nesfatin-1. Peptides 2007;28(12):2372-81. [CrossRef]
12. Merali Z, Cayer C, Kent P, Anisman H. Nesfatin-1 increases anxiety and fear related behaviors in the rat. Psychopharmacology (Berl) 2008;201(1):115-23. [CrossRef]
13. Ari M, Ozturk OH, Bez Y, Oktar S, Erduran D. High plasma nesfatin-1 level in patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2011;35(2):497- 500. [CrossRef]
14. Bez Y, Ari M, Ozturk OH, Oktar S, Can Y, Sadık S. Plasma nesfatin-1 level may be associated with disease severity in patients with panic disorder. Klinik Psikofarmakoloji Bulteni- Bulletin of Clinical Psychopharmacology 2010;20(4):288-92. (Turkish)
15. Bez Y, Ari M, Ozturk OH, Oktar S, Can Y. Increased plasma nesfatin-1 levels in patients with obsessive compulsive disorder. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology 2012;22(1):5-9. (Turkish)
16. Bloem B, Xu L, Morava E, Faludi G, Palkovits M, Roubos EW, et al. Sex-specific differences in the dynamics of cocaine- and amphetamine-regulated transcript and nesfatin-1 expressions in the midbrain of depressed suicide victims vs. controls. Neuropharmacology 2012;62(1):297-303. [CrossRef]
17. Gunay H, Tutuncu R, Aydin S, Dag E, Abasli D. Decreased plasma nesfatin-1 levels in patients with generalized anxiety disorder. Psychoneuroendocrinology 2012;37(12):1949-53. [CrossRef]
18. Yazıcı MK, Demir B, Tanrıverdi N, Karaagaoglu E, Yolac P. Hamilton Anxiety Rating Scale: interrater reliabilty and validity study. Turk Psikiyatri Derg 1998;9(2):114-17. (Turkish)
19. Goebel-Stengel M, Wang L, Stengel A, Tache Y. Localization of nesfatin-1 neurons in the mose brain and functional implication. Brain Res 2011;1396:20-34. [CrossRef]
20. Foo KS, Brismar H, Broberger C. Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/ nesfatin-like immunoreactivity in the rat CNS. Neuroscience 2008;156(3):563-79. [CrossRef]
21. Brailoiu GC, Dun SL, Brailoiu E, Inan S, Yang J, Chang JK, et al. Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology 2007;148(10):5088-94. [CrossRef]
22. Yoshido N, Maejima Y, Sedbazar U, Ando A, Kurita H, Damdindorj B, et al. Stressor-responsive central nesfatin-1 activates corticotropin-releasing hormone, noradrenaline and serotonin neurons and evokes hypothalamic-pituitary- adrenal axis. Aging (Albany NK) 2010;2(11):775-84.
23. Konczol K, Bodnar I, Zelena D, Pinter O, Papp RS, Palkovits M, et al. Nesfatin-1/ NUCB2 may participate in the activation of the hypothalamic-pituitary-adrenal axis in rats. Neurochem Int 2010;57(3):189-97. [CrossRef]
24. Aydin S, Dag E, Ozkan Y, Erman F, Dagli AF, Kilic N, et al. Nesfatin-1 and ghrelin levels in serum and saliva of epileptic patients: hormonal changes can have a major effect on seizure disorders. Mol Cell Biochem 2009;328(1-2):49-56. [CrossRef]
25. Tsuchiya T, Shimizu H, Yamada M,Osaki A, Oh-I S, Ariyama Y, et al. Fasting concentrations of nesfatin-1 are negatively correlated with body mass index in non-obese males. Clin Endocrinol (Oxf) 2010;73(4):484-90.
26. Saldanha JF, Carrero JJ, Lobo JC, Stockler-Pinto MB, Leal VO, Calixto A, et al. The newly identified anorexigenic adipokine nesfatin-1 in hemodialysis patients: are there associations with food intake, body composition and inflammation? Regul Pept 2012;173(1-3):82-5. [CrossRef]

APA	BAHÇECİ B, BAĞCIOĞLU E, Dilek A, CELİK HELVACI F, BAHCECİ I, GONUL Y, HOCAOĞLU Ç (2014). Is there any association between nesfatin-1 and generalized anxiety disorder?. , 55 - 58.
Chicago	BAHÇECİ Bülent,BAĞCIOĞLU Erman,Dilek Aziz Ramazan,CELİK HELVACI Fatmagul,BAHCECİ Ilkay,GONUL Yucel,HOCAOĞLU Çiçek Is there any association between nesfatin-1 and generalized anxiety disorder?. (2014): 55 - 58.
MLA	BAHÇECİ Bülent,BAĞCIOĞLU Erman,Dilek Aziz Ramazan,CELİK HELVACI Fatmagul,BAHCECİ Ilkay,GONUL Yucel,HOCAOĞLU Çiçek Is there any association between nesfatin-1 and generalized anxiety disorder?. , 2014, ss.55 - 58.
AMA	BAHÇECİ B,BAĞCIOĞLU E,Dilek A,CELİK HELVACI F,BAHCECİ I,GONUL Y,HOCAOĞLU Ç Is there any association between nesfatin-1 and generalized anxiety disorder?. . 2014; 55 - 58.
Vancouver	BAHÇECİ B,BAĞCIOĞLU E,Dilek A,CELİK HELVACI F,BAHCECİ I,GONUL Y,HOCAOĞLU Ç Is there any association between nesfatin-1 and generalized anxiety disorder?. . 2014; 55 - 58.
IEEE	BAHÇECİ B,BAĞCIOĞLU E,Dilek A,CELİK HELVACI F,BAHCECİ I,GONUL Y,HOCAOĞLU Ç "Is there any association between nesfatin-1 and generalized anxiety disorder?." , ss.55 - 58, 2014.
ISNAD	BAHÇECİ, Bülent vd. "Is there any association between nesfatin-1 and generalized anxiety disorder?". (2014), 55-58.

APA	BAHÇECİ B, BAĞCIOĞLU E, Dilek A, CELİK HELVACI F, BAHCECİ I, GONUL Y, HOCAOĞLU Ç (2014). Is there any association between nesfatin-1 and generalized anxiety disorder?. Klinik Psikofarmakoloji Bülteni, 24(1), 55 - 58.
Chicago	BAHÇECİ Bülent,BAĞCIOĞLU Erman,Dilek Aziz Ramazan,CELİK HELVACI Fatmagul,BAHCECİ Ilkay,GONUL Yucel,HOCAOĞLU Çiçek Is there any association between nesfatin-1 and generalized anxiety disorder?. Klinik Psikofarmakoloji Bülteni 24, no.1 (2014): 55 - 58.
MLA	BAHÇECİ Bülent,BAĞCIOĞLU Erman,Dilek Aziz Ramazan,CELİK HELVACI Fatmagul,BAHCECİ Ilkay,GONUL Yucel,HOCAOĞLU Çiçek Is there any association between nesfatin-1 and generalized anxiety disorder?. Klinik Psikofarmakoloji Bülteni, vol.24, no.1, 2014, ss.55 - 58.
AMA	BAHÇECİ B,BAĞCIOĞLU E,Dilek A,CELİK HELVACI F,BAHCECİ I,GONUL Y,HOCAOĞLU Ç Is there any association between nesfatin-1 and generalized anxiety disorder?. Klinik Psikofarmakoloji Bülteni. 2014; 24(1): 55 - 58.
Vancouver	BAHÇECİ B,BAĞCIOĞLU E,Dilek A,CELİK HELVACI F,BAHCECİ I,GONUL Y,HOCAOĞLU Ç Is there any association between nesfatin-1 and generalized anxiety disorder?. Klinik Psikofarmakoloji Bülteni. 2014; 24(1): 55 - 58.
IEEE	BAHÇECİ B,BAĞCIOĞLU E,Dilek A,CELİK HELVACI F,BAHCECİ I,GONUL Y,HOCAOĞLU Ç "Is there any association between nesfatin-1 and generalized anxiety disorder?." Klinik Psikofarmakoloji Bülteni, 24, ss.55 - 58, 2014.
ISNAD	BAHÇECİ, Bülent vd. "Is there any association between nesfatin-1 and generalized anxiety disorder?". Klinik Psikofarmakoloji Bülteni 24/1 (2014), 55-58.